Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers.
Murphy-Beiner, A., & Soar, K. | Psychopharmacology | 11 January 2020
Decreased directed functional connectivity in the psychedelic state.
Barnett, L., Muthukumaraswamy, S. D., Carhart-Harris, R. L., & Seth, A. K. | NeuroImage | 17 December 2019
Microdosing psychedelics: Motivations, subjective effects and harm reduction.
Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019
Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., ... & Liechti, M. E. | Neuropsychopharmacology | 16 November 2019
The ethics of psychedelic research in disorders of consciousness.
Peterson, A., Tagliazucchi, E., & Weijer, C. | Neuroscience of Consciousness | 9 October 2019
Exploring ayahuasca‐assisted therapy for addiction: A qualitative analysis of preliminary findings among an Indigenous community in Canada
Argento, E., Capler, R., Thomas, G., Lucas, P., & Tupper, K. W. | Drug and alcohol review | 5 September 2019
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Smigielski, L., Scheidegger, M., Kometer, M., & Vollenweider, F. X. | NeuroImage | 1 August 2019
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
Roseman, L., Haijen, E., Idialu-Ikato, K., Kaelen, M., Watts, R., & Carhart-Harris, R. | Journal of Psychopharmacology | 11 July 2019
Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives
Pallavicini, C., Vilas, M. G., Villarreal, M., Zamberlan, F., Muthukumaraswamy, S., Nutt, D., & Tagliazucchi, E. | NeuroImage | 24 June 2019
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics
Carhart-Harris, R. L., & Friston, K. J. | Pharmacological reviews | 20 June 2019
Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.
Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. | PloS one | 23 April 2019
Psychedelics as a treatment for disorders of consciousness
Scott, G., & Carhart-Harris, R. L. | Neuroscience of consciousness | 21 April 2019
Palliative Nursing and Sacred Medicine: A Holistic Stance on Entheogens, Healing, and Spiritual Care.
Rosa, W. E., Hope, S., & Matzo, M. | Journal of Holistic Nursing | 18 April 2018
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
Neurochemical models of near-death experiences: A large-scale study based on the semantic similarity of written reports.
Martial, C., Cassol, H., Charland-Verville, V., Pallavicini, C., Sanz, C., Zamberlan, F., ... & Tagliazucchi, E. | Consciousness and cognition | 1 February 2019
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial.
Yanakieva, S., Polychroni, N., Family, N., Williams, L. T., Luke, D. P., & Terhune, D. B. | Psychopharmacology | 26 November 2018
Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
Prochazkova, L., Lippelt, D. P., Colzato, L. S., Kuchar, M., Sjoerds, Z., & Hommel, B. | Psychopharmacology | 25 October 2018
Dimensions of consciousness and the psychedelic state
Bayne, T., & Carter, O. | Neuroscience of consciousness | 19 September 2018
It’s Tea Time: Interference of Ayahuasca Brew on Discriminative Learning in Zebrafish
Eduardo-da-Silva, P., Lobao-Soares, B., Amarilha, H., Pinheiro-da-Silva, J., Silva, P. F., & Luchiari, A. C. | Frontiers in behavioral neuroscience | 27 August 2018
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.
Schenberg, E. E. S. | Frontiers in pharmacology | 5 July 2018
The entropic brain – Revisited
Carhart-Harris, R. L. | Neuropharmacology | 13 March 2018
Unifying Theories of Psychedelic Drug Effects
Swanson, L. R. | Frontiers in Pharmacology | 2 March 2018
Psychedelics and connectedness
Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. | Psychopharmacology | 10 August 2017
Entheogenesis: Toward an Expanded Worldview for Our Time
Metzner, R. | Journal of Humanistic Psychology | 9 August 2017